Trials / Terminated
TerminatedNCT05071820
Microlearning Application for Diabetes Prevention
Validation of a Microlearning Approach to a Diabetes Prevention Program
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to test the effectiveness of a mobile application diabetes prevention program delivered with microlearning and microcoaching.
Detailed description
Patients with prediabetes who are interested in joining a diabetes prevention program will be randomized to either the mobile application diabetes prevention program or the traditional diabetes prevention program, which is delivered as a mixed program of in-person and virtual sessions. Study participants in the mobile application version will download the Health U app from the Apple application store. The user will complete the daily microlearning modules and the health coach interactions within the Health U application. The 12-month diabetes prevention program will follow the widely clinically-validated CDC Get Active to Prevent T2 curriculum. For participants participating in the in-person version, they will complete the diabetes prevention program, which meets in-person and virtually approximately once every two weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Health U mobile application | Health U mobile application delivers daily microlearning modules and the health coach interactions within the Health U application |
| OTHER | National Diabetes Prevention Program | CDC recognized National DPP that follows a set curriculum with modules delivered over 12 months |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-09-28
- Completion
- 2023-09-28
- First posted
- 2021-10-08
- Last updated
- 2024-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05071820. Inclusion in this directory is not an endorsement.